Genetic study suggests ‘causal link’ between vitamin D status and blood pressure

By Nathan Gray

- Last updated on GMT

Genetic study suggests ‘causal link’ between vitamin D status and blood pressure

Related tags Blood pressure Hypertension Causality

New genetic research provides ‘compelling evidence’ that low levels of vitamin D have a causal role in the development of high blood pressure, say researchers.

An international study examining the relationship between vitamin D status - measured by 25-hydroxyvitamin D (25[OH]D) concentration – and high blood pressure (hypertension) using mendelian randomisation of more than 100,000 people has suggested that low vitamin D may be causally linked to hypertension.

Led by Professor Elina Hyppönen from the University of South Australia, the team noted that there has been ‘considerable’ interest in the role of vitamin D in hypertension, but until now, a direct causal link has not been shown.

Writing in The Lancet Diabetes & Endocrinology​, the team added that their data also suggests vitamin D supplementation could be effective in combating some cases of high blood pressure.

"In view of the costs and side effects associated with antihypertensive drugs, the potential to prevent or reduce blood pressure and therefore the risk of hypertension with vitamin D is very attractive",​ Hyppönen said.

Writing in a linked comment, Dr Shoaib Afzal and Dr Børge Nordestgaard from Copenhagen University Hospital and the University of Copenhagen in Denmark suggested that  although the  study is 'an important step' towards the description of the role of low vitamin D concentrations in the onset and risk of high blood pressure - "much remains unknown."

"Confirmation of these results in independent, similarly powered studies will be necessary, as will evidence of a corresponding benefit for the prevention of diseases caused by hypertension such as stroke,"​ said Afzal and Nordestgaard.

"Finally, randomised intervention trials will be needed to determine whether vitamin D supplementation can be used to prevent or treat hypertension before such a strategy can be used clinically."

Study details

The new Mendelian randomisation study used genetic data from the D-CarDia collaboration, involving over 146,500 individuals of European ancestry from across Europe and North America. The international team used two common genetic variants that affect circulating 25(OH)D concentrations to measure whether there was a causal effect between vitamin D status and blood pressure and hypertension risk.

For each 10% increase in 25(OH)D concentration there was a drop in diastolic blood pressure (-0.29 mm Hg) and systolic blood pressure (-0.37 mm Hg), and an 8.1% decrease in the odds of developing hypertension, the team found.

"Mendelian randomisation helps to determine cause and effect because by using genetic data we can better avoid confounding, reverse causation, and bias,"​ explained Hyppönen.

"However, because we cannot exclude the possibility that our findings were caused by chance, they need to be replicated in an independent, similarly powered study. Further studies using randomised controlled trials are also needed to confirm causality and the potential clinical benefits of vitamin D supplementation."

Source: The Lancet Diabetes & Endocrinology 
Published online ahead of print, doi: 10.1016/S2213-8587(14)70113-5
"Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study"
Authors: Karani S Vimaleswaran, Alana Cavadino, et al 

Related news

Related products

show more

LocVita® D3: Tailored Formulas & Beadlet Solutions

LocVita® D3: Tailored Formulas & Beadlet Solutions

Content provided by INNOBIO Corporation Limited | 11-Mar-2024 | White Paper

LocVita® Vegan Vitamin D3 delivers specially formulated options that are sugar-free and organic, designed to accommodate various dietary preferences and...

Krill oil supports six key areas of healthy aging

Krill oil supports six key areas of healthy aging

Content provided by Aker BioMarine | 14-Feb-2024 | White Paper

The global population is getting older—according to WHO by 2050 the world’s population over 60 years will double and the population above 80 years will...

Latest Research Findings on Omega-3s for Heart Health

Latest Research Findings on Omega-3s for Heart Health

Content provided by GC Rieber VivoMega™ | 12-Feb-2024 | White Paper

According to Grandview Research, the global omega-3 market is a $2.62 billion market and is one of the fastest-growing segments in the dietary supplement...

Related suppliers

1 comment

stem cell treatment

Posted by katy,

Very good post. Many thanks for you.
<a href="http://cellmalaysia.com" title="stem cell therapy"> stem cell therapy</a>

Report abuse

Follow us

Products

View more

Webinars